Habib Rizk, MD, MSc; Neil P. Monaghan, MD; Sunny Shah, MD; et al.
JAMA Otolaryngol Head Neck Surg. 2024;150(11):935-942. doi:10.1001/jamaoto.2024.2241
This randomized clinical trial analyzes the efficacy of a serotonin-norepinephrine reuptake inhibitor, venlafaxine, compared to placebo in treating adults with Meniere disease.
Najm S. Khan, MBS; Meher Gajula, MS; Lexi Goehring, BS; et al.
JAMA Otolaryngol Head Neck Surg. 2024;150(11):943-951. doi:10.1001/jamaoto.2024.2705
This cohort study examines the bidirectional risk of anxiety and depression for patients with chronic rhinosinusitis.
Qianqian Zhang, MD; Xinyue Gu, MD; Shuangyuan Liu, MD; et al.
JAMA Otolaryngol Head Neck Surg. 2024;150(11):952-959. doi:10.1001/jamaoto.2024.2718
This qualitative survey study examines patients’ experience of decisional conflict when considering active surveillance as an alternative to surgery for low-risk papillary thyroid microcarcinomas.
Gwenaelle Creff, MD, MSc; Nicolas Bernard-Le Liboux, MSc; Paul Coudert, MD, MSc; et al.
JAMA Otolaryngol Head Neck Surg. 2024;150(11):960-968. doi:10.1001/jamaoto.2024.2895
This randomized, double-blind, crossover clinical trial examines the use of a tonotopic map on music perception in new cochlear implant users.
Rebecca Bell, MD; Daniel M. Weinberger, PhD; Manasa Venkatesh, MS; et al.
JAMA Otolaryngol Head Neck Surg. 2024;150(11):969-977. doi:10.1001/jamaoto.2024.3146
This longitudinal study estimates the number of undiagnosed thyroid cancer cases from 2020 to 2021 by comparing observed to expected thyroid cancer incidence in US adults.
-
Invited Commentary
Lower Thyroid Cancer Incidence During the COVID-19 Pandemic—Should We Be Concerned?
Leba Michael Sarkis, MBBS, MS; Antoine Eskander, MD, ScM
JAMA Otolaryngol Head Neck Surg
Ege Akgun, MD; Eren Berber, MD, MBA
JAMA Otolaryngol Head Neck Surg. 2024;150(11):979-985. doi:10.1001/jamaoto.2024.3095
This diagnostic study analyzes the difference in near-infrared autofluorescence signatures of parathyroid glands in single adenomas vs double adenomas and hyperplastic disease.
Ardalan Ebrahimi, MPH; Ruta Gupta, MBBS, MD; Lachlan McDowell, MBBS; et al.
JAMA Otolaryngol Head Neck Surg. 2024;150(11):986-994. doi:10.1001/jamaoto.2024.3103
This cohort study examines key determinants of prognosis in patients with nodal metastatic head and neck cutaneous squamous cell carcinoma.
Vincent Plaforet, MD, MSc; Louis Tournier, MD; Frederic Deschamps, MD, PhD; et al.
JAMA Otolaryngol Head Neck Surg. 2024;150(11):995-1001. doi:10.1001/jamaoto.2024.3228
This case series study evaluates the safety and outcomes of stent-graft placement for treatment of carotid blowout syndrome in patients with head and neck cancer.
James T. O’Hara, MD; Christopher N. Hurt, MSc; Kate Ingarfield, PhD; et al.
open access
JAMA Otolaryngol Head Neck Surg. 2024;150(11):1002-1011. doi:10.1001/jamaoto.2024.3371
This cohort study explores whether the different energy sources used and differing surgical philosophy of transoral robotic surgery and laser microsurgery are associated with postoperative early swallowing function, feeding tube use, and specific factors related to quality of life among patients with human papillovirus–positive oropharyngeal squamous cell carcinoma.
Hyungchae Yang, MD, PhD; Phillip Huyett, MD; Tsai-Yu Wang, MD; et al.
JAMA Otolaryngol Head Neck Surg. 2024;150(11):1012-1019. doi:10.1001/jamaoto.2024.3319
This nonrandomized clinical trial evaluates the overall association of mouth closure with inspiratory airflow and the change in inspiratory airflow with mouth closure across 3 oral-breathing quantiles.
-
Invited Commentary
Should Mouth Taping and Obstructive Sleep Apnea Therapies Be Regulated?
Jeffrey W. Chadwick, DDS, MSc, PhD; Andrew T. Huang, MD
JAMA Otolaryngol Head Neck Surg
Munir Abukhder, MBChB, MSc; Axel Sahovaler, MD; Panagiotis Vrakas, MD, MSc; et al.
JAMA Otolaryngol Head Neck Surg. 2024;150(11):1021-1028. doi:10.1001/jamaoto.2024.3094
This meta-analysis reviews pooled data from studies of frozen section analysis used to evaluate sentinel nodes in patients with cT1-T2 N0 oral squamous cell cancer.